Category
Strategic Themes

New study supports remdesivir as COVID-19 treatment

July 9, 2020
Researchers at the University of North Carolina at Chapel Hill, Vanderbilt University Medical Center and Gilead Sciences report that remdesivir greatly inhibited SARS-CoV-2, the virus that causes COVID-19, in human lung cell cultures and also improved lung function in mice infected with the virus.

Seven new Gillings Innovation Labs will tackle COVID-19

July 6, 2020
Exactly how does coronavirus spread in the air? What will get kids’ vaccinations back on track across the United States? How can public health practitioners work with church communities to spread accurate information about COVID-19? These are just three of the questions being explored by Gillings School researchers and their collaborators through a special COVID-19 round of Gillings Innovation Laboratory awards.